Neuroscience 2003 Abstract
| Presentation Number: | 356.10 |
|---|---|
| Abstract Title: | Effects of methylphenidate on neurogenesis in the dentate gyrus of adolescent rats. |
| Authors: |
Mdzinarishvili, A.*1
; Crews, F.1
1Bowles Ctr. Alcohol Studies, Univ. North Carolina, Chapel Hill, Chapel Hill, NC |
| Primary Theme and Topics |
Development - Neurogenesis and Gliogenesis -- Neural stem cells |
| Secondary Theme and Topics | Development<br />- Neurogenesis and Gliogenesis<br />-- Proliferation |
| Session: |
356. Adult Neurogenesis II Poster |
| Presentation Time: | Monday, November 10, 2003 9:00 AM-10:00 AM |
| Location: | Morial Convention Center - Hall F-I, Board # C11 |
| Keywords: | ADHD, STEM CELL, HIPPOCAMPUS |
Methylphenidate (MP) is a widely prescribed psychotropic medication used for the treatment of attention deficit hyperactivity disorder (ADHD) during early childhood and adolescence. Human studies have suggested that MP reverses hippocampal volume deficits associated with ADHD. The current study was conducted to determine the effects of MP on neural stem cell (NSC) proliferation in the hippocampal dentate gyrus (DG) in adolescent rats. Male Sprague-Dawley rats (100-120g; PND 30-35) were treated with MP (1.0 or 5.0 mg/kg, i.g.) or vehicle. Two hours following MP treatment, bromodeoxyuridine (BrdU -300mg/kg, i.p.) was administered and rats were sacrificed at 7 hours. After 7 hrs, DG BrdU+ cells showed a trend to increase at 1.0 mg/kg MP, but not at 5.0 mg/kg MP. MP and BrdU were given once daily for 5 days to investigate the chronic effects of MP similar to that used clinically. DG BrdU+ cells were increased 52% (p<0.01) by MP after 5 days of treatment. To investigate survival of NSC formed during MP treatment, MP and BrdU were given daily for 5 days as above and animals continued to be treated with MP (1.0 mg/kg) for a total of 30 days. Confirming previous studies, BrdU+ cells decreased over the 30-day period of NSC migration and neuronal differentiation by approximately 70% in both controls and MP treated rats. MP treatment resulted in a 38% (p<0.05) increase in DG BrdU+ cells after 30 days, a time point at which NSC are mainly differentiated into neurons that are known to survive for at least 11 months. These results suggest that MP 1.0 mg/kg significantly increased cell proliferation in the DG of adolescent rats after daily treatment. MP stimulation of neurogenesis could be an important contributor to the increased learning associated with the use of this drug in adolescent humans.
Supported by Supported by NIAAA
Sample Citation:
[Authors]. [Abstract Title]. Program No. XXX.XX. 2003 Neuroscience Meeting Planner. New Orleans, LA: Society for Neuroscience, 2003. Online.
Copyright © 2003-2026 Society for Neuroscience; all rights reserved. Permission to republish any abstract or part of any abstract in any form must be obtained in writing by SfN office prior to publication.